OKLAHOMA PROSTATE CANCER Saturday, September 26, 2015 Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, OK Earn up to 5.5 AMA PRA Category 1 Credits TM Register online: cme.ouhsc.edu
Michael S.Cookson, MD, MMHC (Co-Course Director) THE OKLAHOMA PROSTATE CANCER is held through the University of Oklahoma and the Stephenson Cancer Center to provide new insights in the treatment of prostate cancer. This single-day program will consist of lectures and case discussions highlighting a multidisciplinary approach to prostate cancer care and integration of new technology in the evaluation and treatment of prostate cancer patients. Evidence based medicine highlighting relevant clinical trial data will be provided as well as focusing on current controversies in prostate cancer management. INTENDED/TARGET AUDIENCES Urologists, Medical Oncologists, Radiation Oncologists, Primary Care and Advanced Practice Providers (NP and PA s) LEARNING OBJECTIVES Upon completion of this activity, participants will improve their competence and performance by being able to: 1. Describe guidelines for prostate cancer screening and the difference in recommendations between the various national organizations. 2. Evaluate diagnostic biomarkers and their role in enhanced prostate cancer detection. 3. Identify the use and limitations of prostate MRI in the detection and monitoring of prostate cancer. 4. Identify the new genetic markers and their use in the detection and management of prostate cancer. 5. Describe the risks and benefits of the various treatment modalities for localized prostate cancer, and the impact on cancer control and quality of life. 6. Describe the guidelines and treatment of men with QUESTIONS OKLAHOMA PROSTATE CANCER advanced prostate cancer. If you have any questions, please contact Sharon Kern at (405) 271-2140 or Professor and Chairman Donald D. Albers Chair Department of Urology OU College of Medicine Michael S. Cookson, MD, MMHC, is the Donald D. Albers Professor and Chairman of the Department of Urology at the University of Oklahoma College of Medicine. He is the Director of the Multidisciplinary Prostate and Urologic Oncology Program at the Stephenson Cancer Center. He has 20 years of experience in the management of patients with prostate cancer. His clinical interests include active surveillance, robotic radical prostatectomy and management of high-risk prostate cancer. He has published extensively on the prostate cancer management is the chairman the AUA Guidelines Panel on Castration Resistant Prostate Cancer. Kelly Stratton, MD (Co-Course Director) Assistant Professor Urologic Oncology Department of Urology OU College of Medicine Kelly Stratton, MD, is an assistant professor of Urologic Oncology in the OU Department of Urology. Prior to joining the OU team in 2014, he completed his fellowship training in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York. Dr. Stratton brings experience with state-of-the art imaging for the diagnosis and treatment of prostate cancer. John Davis, MD, FACS Keynote Speaker Associate Professor Urology MD Anderson Cancer Center University of Texas John Davis, MD, FACS, holds Director titles of the Urosurgical Prostate Cancer Program and Urologic Oncology clinics. His clinical interests are in patients with urologic cancers, laparoscopic/ robotic surgery, and general urology. Academic interests include quality of life after prostate cancer treatment, outcomes for robotic radical prostatectomy, high risk prostate cancer trials, and active surveillance for prostate cancer. sharon-kern@ouhsc.edu. CME.OUHSC.EDU
AGENDA Oklahoma Prostate Cancer Symposium Saturday, September 26, 2015 MODERATORS: MICHAEL COOKSON, MD, MMHC AND KELLY STRATTON, MD 6:30 am Breakfast and Exhibits 7:45 am Introduction and Welcome Screening and Early Detection 8:00 am Screening, Early Detection, and Guidelines Brian Cross, MD 8:30 am Beyond PSA: New Markers and Genetic Testing Sanjay Patel, MD 9:00 am Advances in Imaging: MRI and Fusion Biopsy Kelly Stratton, MD Management of Localized Prostate Cancer 9:30 am Active Surveillance Michael Cookson, MD, MMHC 10:00 am Break & Exhibits Key Note Address 10:30 am 11:30 am Surgical Management of intermediate and High Risk Disease Quality Indicators in Localized Prostate Cancer: Past, Present and Future John Davis, MD, FACS Jonathan Heinlein, MD 12:00 pm Lunch & Guest Speaker 1:15 pm Rehabilitation after Treatment for Localized Disease Ash Bowen, MD, MBA 2:00 pm Advances in Radiation Therapy Chance Matthiesen, MD 2:30 pm Treatment of Castration Resistant Disease Michael S. Cookson, MD, MMHC 3:00 pm Question and Answer 3:15 pm Wrap-Up Earn up to 5.5 AMA PRA Category 1 Credits TM
ACCREDITATION STATEMENT OKLAHOMA Register online: cme.ouhsc.edu PROSTATE CANCER NONDISCRIMINATION STATEMENT The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Saturday, Sept. 26, 2015 Oklahoma City, OK The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. OKLAHOMA PROSTATE CANCER CONFLICT RESOLUTION STATEMENT Earn up to 5.5 AMA PRA Category 1 Credits TM The University of Oklahoma, College of Medicine Office of Continuing Professional Development has reviewed this activity s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable. Appropriate acknowledgement will be given to all supporters at the time of the educational activity. The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services. ACCOMMODATION STATEMENT Accommodations on the basis of disability are available by contacting Sharon Kern at (405) 271-2140 or sharon-kern@ouhsc.edu as soon as possible. POLICY ON FACULTY AND PRESENTERS DISCLOSURE It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the course handout materials. ACKNOWLEDGEMENT OF COMMERCIAL AND IN-KIND SUPPORT Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. This course is supported, in part, by educational grants from industry, in accordance with ACCME Standards. At this time, a complete listing of commercial supporters is not available. LIST OF PLANNING COMMITTEE MEMBERS Michael S. Cookson, MD, MMHC (Co-Course Director) Kelly Stratton, MD (Co-Course Director) Abby Moeller, PA-C Chris Shilling Claire Turmelle Sharon Kern (Course Contact) DISCLAIMER STATEMENT Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma ( OU ) nor does OU provide any warranty as to their accuracy or reliability. Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments, or ideas contained in the materials herein.
The Oklahoma Prostate Cancer Symposium will be held in The Charlotte Jackson Seminar Room, Floor 5 of the Stephenson Cancer Center. DIRECTIONS FROM THE SOUTH From I-35, continue on I-235 North Take Exit 1D for Lincoln Blvd. Turn right on NE 10th St. from Lincoln Blvd. Go one block, building is on the right side 800 NE 10th Street Oklahoma City, OK 73104 w: stephensoncancercenter.org p: (405) 271-1112 e: stephensoncancercenter@ouhsc.edu DIRECTIONS FROM THE NORTH From I-235, take Exit 1G at NE 10th St. Turn left onto NE 10th St. Building will be just past Phillips Ave. on the right Valet Parking Provided at No-Cost & Complimentary Garage Parking with Validation This publication, printed by OU Printing Services, is issued by the University of Oklahoma. 1,500 copies have been prepared and distributed at at no cost to the taxpayers of the State of Oklahoma.
The University of Oklahoma College of Medicine Department of Urology and the Irwin H. Brown Office of Continuing Professional Development presents: Oklahoma Prostate Cancer Symposium CME #16003 Saturday, September 26, 2015 Name Middle Last Degree Specialty Address City State ZIP Phone ( ) Fax Emergency Contact Name Phone ( ) Please provide an email adddress that you will be able to access. This adresss will be used to send evaluations links and updates. *Email *Please indicate whether you consent to the receipt of future electronic messages from the University of Oklahoma College of Medicine, Office of Continuing Professional Development, by marking the box in the affirmative and by executing where noted below and providing us with your email address. We will not share your email or contact information with anyone outside of the CPD office. I consent to the receipt of future electronic messages from the University of Oklahoma College of Medicine, Office of CPD I decline to receive future electronic messages from the University of Oklahoma College of Medicine, Office of CPD initial Physician (MD, DO) Physician Assistant, Nurse Practitioner, Other Health Care Prfessional The annual conference registration fee includes course materials, CME credit, breakfast, breaks, and lunch. No registration refunds will be made after Sept. 14. Written notification of cancellation must be postmarked before Sept. 14. Cancellation fee is $75. Confirmations will be emailed. (This annual conference is subject to cancellation if registration is insufficient, in which case all registration fees will be refunded.) Please register early, as space is limited. Earlybird Registration Fee (Postmarked by 9/11/15) $100 $25 Regular Registration Fee (After 9/11/15) Residents, Fellows $0 $0 Payment is due with registration; purchase orders are accepted and may be sent with registration. Make checks payable to OUHSC-CPD. (Tax ID #73-601-7987) Online Registration: cme.ouhsc.edu/ No registration refunds will be made after Sept. 30. Must be postmarked by Sept. 30. $125 $25 Please check method of payment for total fee: Check enclosed ( # ) We accept: Visa Mastercard Discover Total Amount Charged $ Card Number: Expiration Date: Today s Date: Signature: Name as it appears on card (please print): OUHSC Departmental Transfers: CPD Chartfield: ORG (COM015), FUND (MISCA), PROG (00014), SUBCLASS (00000), PROJ GRANT (N/A) DETACH AND MAIL WITH PAYMENT TO: OUHSC - Office of CPD, PO Box 26901, ROB 202, Oklahoma City, OK 73126-0901 Telephone (405) 271-2350, Ex: 6, Fax (405) 271-3087 Toll Free 1 (888) 682-6348 Please share this brochure with your colleagues.
OKLAHOMA PROSTATE CANCER Saturday, September 26, 2015 OU Health Sciences Center, Oklahoma City 800 NE 10th Street, Oklahoma City, OK 73104 OU Health Sciences Center Campus